Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-1.
Gormez S, Gumusel HK, Ekicibasi E, Degirmencioglu A, Paudel A, Akan G, Atalar F, Erdim R, Eroglu E, Dagdelen S, Sariguzel N, Kirisoglu CE, Pamukcu B.
Gormez S, et al.
Bratisl Lek Listy. 2021;122(8):582-589. doi: 10.4149/BLL_2021_093.
Bratisl Lek Listy. 2021.
PMID: 34282625